15 March 2017

Paul Scheepers, dept for Health Evidence, was appointed by DG SANTE as risk assessment expert to support the European Commission in the case of serious cross-border chemical health threats.

This task is performed in the context of decision 1082/2013/EU to respond to incidents or alerts of serious cross-border health threats. When a coordinated response at EU level is required, the Commission involve experts to prepare an assessment of the severity of the public health threat, including possible public health measures. These incidents may include both manmade and naturally occurring events. It is also possible that the EU deploys experts in such incidents outside the EU on request of one of the EU member states. This occurred on request of France in the earthquake in Haiti in 2010. Paul Scheepers will contribute to preparing ad hoc rapid risk assessments in collaboration with field officers deployed on location. For this task he was trained in November last year and in March this year he will receive further. He has prior experience as public health advisor hazardous materials (GAGS) for five safety regions in the South of The Netherlands since 2007. In 2012 he contributed to establish a national guidance on human biological monitoring following chemical incidents and published two scientific papers on this subject. He supported the use of biomonitoring in response to a train incident on May 4th 2013 in Wetteren near Ghent in Belgium. This incident resulted in 33 injuries, 1 fatality and exposure of thousands of inhabitants and hundreds of first responders to acrylonitrile. In 2014 he edited a special issue of Toxicology Letters on the application of biomonitoring in response to chemical incidents.

More information: link
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Health Evidence

Related news items


The PRIDE Study Evaluation of online methods of data collection

16 January 2020 In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study. read more

Social media posts on medication use during pregnancy often incorrect

23 August 2019 Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines. read more

Bart Kiemeney finishes 1st in the Tour and raises thousands of euros

30 July 2019 With over €47,000 on the counter, Kiemeney can see the Tour de France as a great success. read more

Ingenious solution, but what was the problem?

29 May 2019 In Value in Health Anouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt and Janneke Grutters found, using a mixed methods approach, that although a recently developed medical technology was deemed ingenious by stakeholders, there was no underlying problem it could solve in its intended context. read more

Association of gestational weight gain with adverse maternal and infant outcomes

13 May 2019 An individual participant meta-analysis published in JAMA showed that pregnancy BMI is related stronger to maternal and infant complications than to gestational weight gain. The PRIDE Study, with coauthors Marleen van Gelder and Nel Roeleveld, was one of the participating cohorts. read more

Eddy Adang reappointed as member Health Council

21 November 2018 The Health Council of the Netherlands is an independent scientific advisory body whose legal task it is to advise ministers and Parliament in the field of public health and health/healthcare research. read more